Pharvaris (PHVS) Change in Account Payables (2020 - 2026)
Pharvaris (PHVS) reported Change in Account Payables of -$5.5 million for Q1 2026, down 1462.15% on a YoY basis from $406477.4 in Q1 2025, and down 1462.15% quarter-over-quarter from -$354436.7 in Q1 2025.
Pharvaris (PHVS) Change in Account Payables (2020 - 2026) Analysis & Trends
Pharvaris has reported Change in Account Payables for 6 years, with the latest figure at -$5.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 1462.15% year-over-year to -$5.5 million; the trailing twelve-month figure through Mar 2026 stood at -$5.3 million (down 266.28% YoY), and the FY2025 full-year result was -$29272.3, down 101.64% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$5.5 million, down from -$354436.7 in the prior quarter.
- The five-year high for Change in Account Payables was $3.0 million in Q3 2022, with the low at -$5.5 million in Q1 2026.
- Historically, Change in Account Payables has averaged -$73005.5 across 4 years, with a median of $879352.9 in 2022.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 603.06% — and 2026, when it plunged 1462.15%.
- Pharvaris' Change in Account Payables stood at -$713969.1 in 2022, then jumped by 282.77% to $1.3 million in 2023, then tumbled by 127.16% to -$354436.7 in 2025, then sank by 1462.15% to -$5.5 million in 2026.
- The last three Change in Account Payables figures came in at -$5.5 million (Q1 2026), -$354436.7 (Q1 2025), and $1.3 million (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -9.42 Mn |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - | -5.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.54 Mn |
| Mar 31, 2026 | -5.54 Mn |
| Mar 31, 2025 | -354,436.67 |
| Mar 31, 2025 | -354,436.67 |
| Mar 31, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | -713,969.11 |
| Dec 31, 2022 | -713,969.11 |
| Sep 30, 2022 | 2.95 Mn |
| Sep 30, 2022 | 2.95 Mn |
| Jun 30, 2022 | 879,352.88 |
| Jun 30, 2022 | 879,352.88 |
| Mar 31, 2022 | 958,803.01 |
| Mar 31, 2022 | 958,803.01 |
| Dec 31, 2021 | -1.21 Mn |
| Dec 31, 2021 | -1.21 Mn |
| Sep 30, 2021 | 419,751.99 |
| Sep 30, 2021 | 419,751.99 |
| Jun 30, 2021 | -1.36 Mn |
| Jun 30, 2021 | -1.36 Mn |